Ovation Science Inc. (OVATF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -336.02 Thousand | -670.8 Thousand | -885.75 Thousand | -1.38 Million | -952.9 Thousand | -382.91 Thousand |
| Net Income | -813.14 Thousand | -794.05 Thousand | -2.39 Million | -1.18 Million | -835.94 Thousand | -508.4 Thousand |
| Depreciation & Amortization | 3240.00 | 6731.00 | 8022.00 | 8605.00 | 2573.00 | - |
| Deferred income taxes | - | - | - | 40.57 Thousand | -47.06 Thousand | - |
| Stock-based compensation | 37.7 Thousand | - | - | 413.02 Thousand | 94.82 Thousand | 22.55 Thousand |
| Change in working capital | 319.56 Thousand | 121.77 Thousand | -83.48 Thousand | -666.12 Thousand | -176.5 Thousand | 19.79 Thousand |
| Other non-cash items | -154.51 Thousand | -5254.00 | 1.58 Million | 3651.00 | 9210.00 | 83.12 Thousand |
| Investing Cash Flow | - | - | 1.15 Million | -685.18 Thousand | 895.19 Thousand | -1.5 Million |
| Investments in PPE | - | - | - | -135.18 Thousand | -31.66 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -550 Thousand | - | -1.5 Million |
| Sales/Maturities of investments | - | - | 1.15 Million | - | 926.86 Thousand | - |
| Other Investing Activities | - | - | 1.15 Million | -685.18 Thousand | 926.86 Thousand | -1.5 Million |
| Financing Cash Flow | 356.15 Thousand | 47.24 Thousand | - | 2.05 Million | -28.15 Thousand | 2.06 Million |
| Debt repayment | -172.15 Thousand | -47.24 Thousand | - | -104.47 Thousand | -55.83 Thousand | -430.94 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 184 Thousand | 20 Thousand | - | 1.96 Million | 27.68 Thousand | 2.1 Million |
| Other Financing Activities | -16 Thousand | 47.24 Thousand | - | 186.18 Thousand | -28.15 Thousand | 385.99 Thousand |
| Accounts receivables | -5077.00 | 36.15 Thousand | -44.01 Thousand | 6149.00 | -3888.00 | -37.64 Thousand |
| Accounts payables | 346.15 Thousand | 79.63 Thousand | -79.53 Thousand | 60.91 Thousand | -98.4 Thousand | 151.72 Thousand |
| Inventory | -25.76 Thousand | 813.00 | 37.46 Thousand | -775.27 Thousand | -85.6 Thousand | -25.52 Thousand |
| Other working capital | 4257.00 | 5169.00 | 2598.00 | 42.07 Thousand | 11.39 Thousand | -106.39 Thousand |
| Cash at beginning of period | 28.9 Thousand | 647.56 Thousand | 380.62 Thousand | 378.75 Thousand | 468.96 Thousand | 277.95 Thousand |
| Cash at end of period | 48.84 Thousand | 28.9 Thousand | 647.56 Thousand | 380.62 Thousand | 378.75 Thousand | 468.96 Thousand |
| Capital Expenditure | - | - | - | -135.18 Thousand | -31.66 Thousand | - |
| Effect of forex changes on cash | -186.00 | 4901.00 | -4883.00 | 21.86 Thousand | -4357.00 | 12.25 Thousand |
| Net cash flow / Change in cash | 19.94 Thousand | -618.66 Thousand | 266.94 Thousand | 1865.00 | -90.21 Thousand | 191.01 Thousand |
| Free Cash Flow | -336.02 Thousand | -670.8 Thousand | -885.75 Thousand | -1.52 Million | -984.56 Thousand | -382.91 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -75.81 Thousand | -176.02 Thousand | -813.14 Thousand | -191.97 Thousand | -193.17 Thousand | -262.04 Thousand |
| Depreciation & Amortization | 819.00 | 806.00 | 3240.00 | 825.00 | 812.00 | 803.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 37.7 Thousand | 37.7 Thousand | - | - |
| Change in working capital | 37.11 Thousand | 71.33 Thousand | 319.56 Thousand | -81.13 Thousand | 104.66 Thousand | 164.48 Thousand |
| Other non-cash items | -90.16 Thousand | -46.03 Thousand | -154.51 Thousand | 217.07 Thousand | 22.43 Thousand | 3417.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 64.94 Thousand | 67.62 Thousand | 356.15 Thousand | 192.9 Thousand | 61.26 Thousand | 57.36 Thousand |
| Debt repayment | -64.94 Thousand | - | -172.15 Thousand | -8901.00 | -61.26 Thousand | -57.36 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 67.62 Thousand | 184 Thousand | 184 Thousand | - | - |
| Other Financing Activities | 64.94 Thousand | 67.62 Thousand | -16 Thousand | -26 Thousand | 61.26 Thousand | 57.36 Thousand |
| Accounts receivables | -35.69 Thousand | -3636.00 | -5077.00 | 2174.00 | -6911.00 | 5656.00 |
| Accounts payables | 66.28 Thousand | 81.1 Thousand | 346.15 Thousand | -94.19 Thousand | 106.76 Thousand | 180.28 Thousand |
| Inventory | 876.00 | -11.16 Thousand | -25.76 Thousand | 5217.00 | 1412.00 | -18.73 Thousand |
| Other working capital | 5647.00 | 5029.00 | 4257.00 | 5662.00 | 3407.00 | -2728.00 |
| Cash at beginning of period | 31.29 Thousand | 48.84 Thousand | 28.9 Thousand | 6397.00 | 2200.00 | 39.98 Thousand |
| Cash at end of period | 9200.00 | 31.29 Thousand | 48.84 Thousand | 48.84 Thousand | 6397.00 | 2200.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 11.16 Thousand | 42.00 | -186.00 | -6788.00 | 8183.00 | -1817.00 |
| Net cash flow / Change in cash | -22.09 Thousand | -17.55 Thousand | 19.94 Thousand | 42.45 Thousand | 4197.00 | -37.78 Thousand |
| Free Cash Flow | -98.2 Thousand | -85.22 Thousand | -336.02 Thousand | -143.66 Thousand | -65.25 Thousand | -93.33 Thousand |
4162
301012
CIG
NWGL
GARB
000970